Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mauri

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
Lung Cancer (Amsterdam, Netherlands)|August 2, 2011
Overexpression of the mammalian target of rapamycin (mTOR) and angioinvasion are poor prognostic factors in early stage NSCLC: a verification studyK Gately, B Al-Alao, T Dhillon, et al.
The American Journal of Cardiology|May 15, 1989
One-year prognosis of primary ventricular fibrillation complicating acute myocardial infarction. The GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto miocardico) investigatorsA Volpi, A Cavalli, M G Franzosi, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|April 1, 1995
Heterozygosity for homocysteinuria: a detectable and reversible risk factor for pulmonary thromboembolismM Confalonieri, P Parigi, A Scartabellati, et al.
The New England Journal of Medicine|November 11, 1993
Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2)A P Maggioni, A Maseri, C Fresco, et al.
Circulation|August 1, 1987
The GISSI Study: further analysis. Italian Group for the Study of Streptokinase in Myocardial Infarction (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico, GISSI)M G Franzosi, F Mauri, S Pampallona, et al.
Applied Pathology|January 1, 1986
Neuroendocrine structures in normal and diseased human lungL Mosca, A Ceresoli, E Anzanello, et al.
La Clinica Terapeutica|December 15, 1989
[Clinico-laboratory evaluation a new sustained-release preparation of anhydrous theophylline]L Gandola, S Aiolfi, F Soccini, et al.
Recenti Progressi in Medicina|July 1, 1991
[Severe bronchial spasm crises induced by topical administration of eyedrops with timolol base, a non-selective beta blocking agent]M Confalonieri, S Aiolfi, G Patrini, et al.
La Clinica Terapeutica|September 15, 1990
[Intravenous pentoxifylline in Fontaine stage II and III peripheral arterial diseases]C Giansante, A Di Chiara, N Fiotti, et al.
The American Journal of Cardiology|July 15, 1996
Trends and determinants of calcium antagonist usage after acute myocardial infarction (the GISSI experience)G Zuanetti, R Latini, F Avanzini, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
Lung Cancer (Amsterdam, Netherlands)|August 2, 2011
Overexpression of the mammalian target of rapamycin (mTOR) and angioinvasion are poor prognostic factors in early stage NSCLC: a verification studyK Gately, B Al-Alao, T Dhillon, et al.
The American Journal of Cardiology|May 15, 1989
One-year prognosis of primary ventricular fibrillation complicating acute myocardial infarction. The GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto miocardico) investigatorsA Volpi, A Cavalli, M G Franzosi, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|April 1, 1995
Heterozygosity for homocysteinuria: a detectable and reversible risk factor for pulmonary thromboembolismM Confalonieri, P Parigi, A Scartabellati, et al.
The New England Journal of Medicine|November 11, 1993
Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2)A P Maggioni, A Maseri, C Fresco, et al.
Circulation|August 1, 1987
The GISSI Study: further analysis. Italian Group for the Study of Streptokinase in Myocardial Infarction (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico, GISSI)M G Franzosi, F Mauri, S Pampallona, et al.
Applied Pathology|January 1, 1986
Neuroendocrine structures in normal and diseased human lungL Mosca, A Ceresoli, E Anzanello, et al.
La Clinica Terapeutica|December 15, 1989
[Clinico-laboratory evaluation a new sustained-release preparation of anhydrous theophylline]L Gandola, S Aiolfi, F Soccini, et al.
Recenti Progressi in Medicina|July 1, 1991
[Severe bronchial spasm crises induced by topical administration of eyedrops with timolol base, a non-selective beta blocking agent]M Confalonieri, S Aiolfi, G Patrini, et al.
La Clinica Terapeutica|September 15, 1990
[Intravenous pentoxifylline in Fontaine stage II and III peripheral arterial diseases]C Giansante, A Di Chiara, N Fiotti, et al.
The American Journal of Cardiology|July 15, 1996
Trends and determinants of calcium antagonist usage after acute myocardial infarction (the GISSI experience)G Zuanetti, R Latini, F Avanzini, et al.
Pageof 11